Brandi L. Roberts
Overview
Brandi L. Roberts received an average of $1M in total compensation, including $408K in salary, at Longboard Pharmaceuticals from 2021 to 2023. Brandi Roberts also received $948K at BioTime in 2019, $842K at REVA Medical in 2017, and an average of $665K at Mast Therapeutics from 2015 to 2017.
- 2023
- 2022
- 2021
- 2019
- 2017
- 2016
- 2015
Longboard PharmaceuticalsExecutive Vice President and Chief Financial Officer
Longboard PharmaceuticalsExecutive Vice President and Chief Financial Officer
Longboard PharmaceuticalsChief Financial Officer
BioTimeChief Financial Officer
Mast TherapeuticsFormer Chief Financial Officer & Senior Vice President
REVA MedicalChief Financial Officer, SVP and Secretary
Mast TherapeuticsFormer Chief Financial Officer & Senior Vice President
Mast TherapeuticsFormer Chief Financial Officer & Senior Vice President
Source: SEC filings on April 12, 2024, April 11, 2023, April 13, 2022, August 7, 2020, April 23, 2018, and April 5, 2018.
Related executives
We found 47 more executives who work or worked at Longboard Pharmaceuticals, BioTime, REVA Medical, andMast Therapeutics.
Kevin Lind
Longboard Pharmaceuticals
Chief Executive Officer
Randall Kaye
Longboard Pharmaceuticals
Chief Medical Officer
Brian Culley
BioTime
Chief Executive Officer
Kevin Cook
BioTime
Chief Financial Officer
George Samuel
BioTime
General Counsel
Jill Howe
BioTime
Chief Financial Officer
Matthew Pauls
Mast Therapeutics
Chief Executive Officer
Badrul Chowdhury
Mast Therapeutics
Chief Medical Officer
News
Longboard Pharmaceuticals CEO Kevin Lind's 2023 pay jumps 36% to $2.1M
April 12, 2024
Longboard Pharmaceuticals CEO Kevin Lind's 2022 pay jumps 72% to $1.5M
April 11, 2023
Longboard Pharmaceuticals CFO Brandi Roberts receives $1.3M in 2021
April 13, 2022
BioTime CFO Brandi Roberts receives $948K in 2019
August 7, 2020